ATIII, goat milk, GTC Biotherapeutics
ATryn®, recombinant form of human ntithrombin,
is the first transgenically produced protein to be approved anywhere in the world, having recently been approved by the European Commission for the prophylactic treatment of deep vein thrombosis in patients with hereditary antithrombin deficiencies that are undergoing surgical procedures.